Early Stage Venture RayzeBio Raises Series A of $45000000

About RayzeBio

RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes.

Website: Learn more on RayzeBio’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – RayzeBio

Amount Raised	45000000 USD
Announced Date	2020-10-14
Equity Only Funding	Yes
Organization Location	San Diego, California, United States, North America
Funding Status	Early Stage Venture
Number of Funding Rounds	1
Lead Investors	venBio Partners, Versant Ventures
Number of Investors	3
Number of Partner Investors	2